Olga Kulikova

Dr. Olga Kulikova

Research Center of Neurology, Moscow, Moskva, Russia
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2018 in Amino Acids
Verified
Journal Article
Closed access
PDF file
DBDaniil Berezhnoy
Daniil Berezhnoy
SSS. L. Stvolinsky
S. L. Stvolinsky
ALA. V. Lopachev
A. V. Lopachev
ADA. A. Devyatov
A. A. Devyatov
OLO. M. Lopacheva
O. M. Lopacheva
TFT. N. Fedorova
T. N. Fedorova

4 January 2020 in DARU Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
OKOlga Kulikova
Olga Kulikova
SSSergey L. Stvolinsky
Sergey L. Stvolinsky
VMVasily A. Migulin
Vasily A. Migulin
LALudmila A. Andreeva
Ludmila A. Andreeva
INIgor Yu. Nagaev
Igor Yu. Nagaev
TFTatiana N. Fedorova
Tatiana N. Fedorova

1 June 2018 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Closed access
OKOlga Kulikova
Olga Kulikova
DBDaniil Berezhnoy
Daniil Berezhnoy
SSSergey L. Stvolinsky
Sergey L. Stvolinsky
ALAlexander V Lopachev
Alexander V Lopachev
VOValentina S. Orlova
Valentina S. Orlova
TFTatiana Fedorova
Tatiana Fedorova

1 August 2021 in Brain Research Bulletin
Verified
Journal Article
Closed access
DTDmitry Troshev
Dmitry Troshev
DBDaniil Berezhnoy
Daniil Berezhnoy
OKOlga Kulikova
Olga Kulikova
DADenis Abaimov
Denis Abaimov
OMOlga Muzychuk
Olga Muzychuk
TFTatiana Fedorova
Tatiana Fedorova

4 June 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
OKOlga Kulikova
Olga Kulikova
DTDmitry Troshev
Dmitry Troshev
DBDaniil Berezhnoy
Daniil Berezhnoy
SSSergey Stvolinsky
Sergey Stvolinsky
YTYulia Timoshina
Yulia Timoshina
TFTatiana Fedorova
Tatiana Fedorova
Oxidative stress, accompanied by mitochondrial dysfunction, is a key mechanism involved in the pathogenesis of Parkinson’s disease (PD). Both carnosine and lipoic acid are potent antioxidants, the applicability of which in therapy is hindered by their limited bioavailability. This study aimed to evaluate the neuroprotective properties of a nanomicellar complex of carnosine and lipoic acid (CLA) in a rotenone-induced rat model of PD. Parkinsonism was induced via the administration of 2 mg/kg rotenone over the course of 18 days. Two doses of intraperitoneal CLA (25 mg/kg and 50 mg/kg) were administered alongside rotenone to assess its neuroprotective effect. At 25 mg/kg CLA decreased muscle rigidity and partially restored locomotor activity in animals that received rotenone. Furthermore, it caused an overall increase in brain tissue antioxidant activity, accompanied by a 19% increase in neuron density in the substantia nigra and increased dopamine levels in the striatum relative to animals that only received rotenone. Based on the acquired results, it may be concluded that CLA have neuroprotective properties and could potentially be beneficial in PD treatment when used in conjunction with the base therapy.

1 October 2016 in Moscow University Biological Sciences Bulletin
Verified
Journal Article
Closed access
PDF file
OKOlga Kulikova
Olga Kulikova
TFT. N. Fedorova
T. N. Fedorova
SSS. L. Stvolinsky
S. L. Stvolinsky
VOV. S. Orlova
V. S. Orlova
AIA. N. Inozemtsev
A. N. Inozemtsev